{"timestamp": 1771603014.6279721, "value": {"ticker": "APRE", "company_name": "Aprea Therapeutics, Inc.", "short_name": "Aprea Therapeutics, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 5455193, "float_shares": 4713568, "shares_outstanding": 6993838, "short_ratio": 0.05, "short_percent_of_float": 0.040999997, "shares_short": 260110, "shares_short_prior": 35625, "insider_percent_held": 0.19624001, "institution_percent_held": 0.24267, "total_cash": 13718052, "total_debt": 0, "total_revenue": 488239, "revenue_growth": -0.995, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": -1686.8983, "debt_to_equity": 0, "current_ratio": 5.201, "book_value": 1.825, "price_to_book": 0.42739722, "operating_cashflow": -13444051, "free_cashflow": -9065156, "price": 0.78, "52w_high": 3.715, "52w_low": 0.548, "avg_volume": 2074780, "avg_volume_10d": 571940, "full_time_employees": 8, "audit_risk": 9, "overall_risk": 9}}